Wealth Alliance Advisory Group’s Ginkgo Bioworks DNA Stock Holding History

Wealth Alliance Advisory Group’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-372	Closed	-$25.1K	–	192
2023 Q4	$25.1K	Sell	372 -372	-50%	-$22.8K	0.01%	181
2023 Q3	$53.8K	Hold	744	–	–	0.02%	177
2023 Q2	$55.3K	Buy	+744	New	+$44K	0.02%	168
2023 Q1	–	Sell	-452	Closed	-$30.6K	–	170
2022 Q4	$30.6K	Buy	+452	New	+$41.6K	0.01%	168

Other funds holding DNA

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wealth Alliance Advisory Group's DNA Position: Q1 2024 in Review

Wealth Alliance Advisory Group sold out of Ginkgo Bioworks (DNA) in Q1 2024, closing a stake of 372 shares — an estimated $25.1K sold.

Wealth Alliance Advisory Group first reported a position in DNA in Q4 2022 and held it in 4 quarters. The position peaked at $55.3K in Q2 2023. 342 funds tracked by Wall St. Rank hold DNA as of Q1 2024.

Wealth Alliance Advisory Group reported no remaining Ginkgo Bioworks position as of Q1 2024 after selling out during the quarter.
Wealth Alliance Advisory Group sold 372 Ginkgo Bioworks shares in Q1 2024, an estimated $25.1K.
Wealth Alliance Advisory Group first reported a position in Ginkgo Bioworks in Q4 2022 and held it in 4 quarters.
Wealth Alliance Advisory Group's Ginkgo Bioworks position peaked at $55.3K in Q2 2023.
342 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2024.

Based on Wealth Alliance Advisory Group's 13F filing for Q1 2024, filed 15 Apr 2024.